In the past week, GDRX stock has gone down by -0.30%, with a monthly gain of 3.21% and a quarterly surge of 5.47%. The volatility ratio for the week is 5.78%, and the volatility levels for the last 30 days are 5.77% for GoodRx Holdings Inc The simple moving average for the last 20 days is -5.04% for GDRX’s stock, with a simple moving average of 8.67% for the last 200 days.
Is It Worth Investing in GoodRx Holdings Inc (NASDAQ: GDRX) Right Now?
Moreover, the 36-month beta value for GDRX is 1.43. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GDRX is 76.60M and currently, short sellers hold a 12.65% of that float. On March 22, 2024, GDRX’s average trading volume was 1.69M shares.
GDRX) stock’s latest price update
GoodRx Holdings Inc (NASDAQ: GDRX) has experienced a decline in its stock price by -0.74 compared to its previous closing price of 6.80. However, the company has seen a fall of -0.30% in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-15 that The consensus price target hints at a 29.1% upside potential for GoodRx Holdings, Inc. (GDRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with JP Morgan repeating the rating for GDRX by listing it as a “Overweight.” The predicted price for GDRX in the upcoming period, according to JP Morgan is $10 based on the research report published on March 01, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $8. The rating they have provided for GDRX stocks is “Outperform” according to the report published on February 26th, 2024.
BofA Securities gave a rating of “Underperform” to GDRX, setting the target price at $4.50 in the report published on January 02nd of the current year.
GDRX Trading at 1.00% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.96% of loss for the given period.
Volatility was left at 5.77%, however, over the last 30 days, the volatility rate increased by 5.78%, as shares surge +3.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.21% upper at present.
During the last 5 trading sessions, GDRX fell by -0.30%, which changed the moving average for the period of 200-days by +25.23% in comparison to the 20-day moving average, which settled at $7.12. In addition, GoodRx Holdings Inc saw 0.75% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GDRX starting from Wagner Scott, who purchase 21,652 shares at the price of $5.76 back on Nov 30 ’23. After this action, Wagner Scott now owns 182,900 shares of GoodRx Holdings Inc, valued at $124,806 using the latest closing price.
Wagner Scott, the of GoodRx Holdings Inc, purchase 26,348 shares at $5.90 during a trade that took place back on Nov 29 ’23, which means that Wagner Scott is holding 161,248 shares at $155,482 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.85 for the gross margin
The net margin for GoodRx Holdings Inc stands at -0.01. The total capital return value is set at -0.01. Equity return is now at value -1.12, with -0.55 for asset returns.
Based on GoodRx Holdings Inc (GDRX), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 0.87. The interest coverage ratio of the stock is -0.33.
Currently, EBITDA for the company is 163.15 million with net debt to EBITDA at 0.37. When we switch over and look at the enterprise to sales, we see a ratio of 3.61. The receivables turnover for the company is 4.69for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.12.
Conclusion
To wrap up, the performance of GoodRx Holdings Inc (GDRX) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
